ECRG4 and breast cancer: Correlation analysis of C2ORF40 protein expression with clinicopathologic features revealed significant association between deficiency of C2ORF40 expression and TNM stage, metastasis and differentiation (Figure 1E and 1F; Table 1), indicating the involvement of C2ORF40 deficiency in breast cancer progression.